Robert Cohen - Jun 1, 2021 Form 4 Insider Report for Zomedica Corp. (ZOM)

Role
CEO, Director
Signature
/s/ John Hogoboom, as attorney-in-fact
Stock symbol
ZOM
Transactions as of
Jun 1, 2021
Transactions value $
-$1,941,318
Form type
4
Date filed
6/1/2021, 04:43 PM
Next filing
Jun 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZOM Common Stock, without par value Options Exercise $380K +2M $0.19 2M Jun 1, 2021 Direct
transaction ZOM Common Stock, without par value Options Exercise $275K +1.19M +59.69% $0.23 3.19M Jun 1, 2021 Direct
transaction ZOM Common Stock, without par value Sale -$2.6M -3.19M -100% $0.81 0 Jun 1, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZOM Stock option (right to buy) Options Exercise $0 -2M -100% $0.00* 0 Jun 1, 2021 Common Stock, without par value 2M $0.19 Direct F3
transaction ZOM Stock option (right to buy) Options Exercise $0 -1.19M -9.95% $0.00 10.8M Jun 1, 2021 Common Stock, without par value 1.19M $0.23 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.8499 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3 Options fully vested.
F4 The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021.